The City - July 5, 2022
Antoinette Danvers, M.D., explains the importance of abortion training and Montefiore and Einstein's efforts to offer it to medical residents in states where abortion is now illegal. Dr. Danvers is associate professor of obstetrics & gynecology and women's health at Einstein and director of the division of complex family planning at Montefiore.
Dr. Danvers' Profile
MedPageToday - July 1, 2022
In a MedPage Today commentary, Einstein medical students Sarah McNeilly and Vivian Kim call for national organizations overseeing medical education to implement a universal curricular standard for abortion education.
Academic Minute - June 22, 2022
Steven Walkley, D.V.M., Ph.D., describes "gene teams" at Einstein and Montefiore in which physicians and scientists provide clinical information and research updates to parents of children diagnosed with rare genetic diseases. Dr. Walkley is co-director of the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center and professor in the Dominick P. Purpura Department of Neuroscience, of pathology, and in the Saul R. Korey Department of Neurology.
Dr. Walkley's ProfileMore coverage on Dr. Walkley
MedPageToday - June 19, 2022
Liise-anne Pirofski, M.D., co-authored a commentary on the benefits of convalescent plasma for treating immunocompromised patients who have COVID-19. Dr. Pirofski is chief of infectious diseases at Einstein and Montefiore, professor of medicine and of microbiology & immunology, and holds the Selma and Dr. Jacques Mitrani Chair in Biomedical Research at Einstein.
Dr. Pirofski's ProfileMore coverage on Dr. Pirofski
The Scientist - June 16, 2022
Meredith Hawkins, M.D., M.S., explains her study that describes a metabolically distinct type of diabetes characterized by low body weight and problems with insulin secretion—a crucial step toward developing effective treatments. Dr. Hawkins is the founding director of the Global Diabetes Institute, professor of medicine, and the Harold and Muriel Block Chair in Medicine at Einstein.
Additional coverage includes UPI and The Hindu
Dr. Hawkins' ProfileMore coverage on Dr. Hawkins
Medscape - June 1, 2022
Noa Schwartz, M.D., M.S., comments on the discovery of a rare mutation in a person with systemic lupus erythematosus and the possibility that it could lead to new treatments for a subset of patients with the disease. Dr. Schwartz is assistant professor of medicine at Einstein and director of the Montefiore-Einstein Institute for Lupus Care and Research.
Dr. Schwartz's Profile
CNN - May 31, 2022
Joe Verghese, M.B.B.S., M.S., comments on a study that found adults over age 65 had an increased risk of dementia if they had both a decrease in their walking speed and signs of cognitive function decline. Dr. Verghese is chief of the integrated divisions of cognitive and motor aging and of geriatrics at Einstein and Montefiore. He also is the Murray D. Gross Memorial Faculty Scholar in Gerontology, director of the Resnick Gerontology Center, and professor in the Saul R. Korey Department of Neurology and of medicine at Einstein.
Additional coverage includes MedPage Today, Medscape
Dr. Verghese's ProfileMore coverage on Dr. Verghese
The New York Times - May 31, 2022
Simon Rego, Psy.D., says looking forward to things improves our mood and can make us less irritable. Dr. Rego is associate professor of psychiatry and behavioral sciences, chief of psychology, and director of psychology training at Einstein and Montefiore.
Dr. Rego's ProfileMore coverage on Dr. Rego
WNYC - May 26, 2022
Seth Congdon, M.D., describes the common and often debilitating symptoms of long COVID and stresses the importance of following up with physicians and specialists to address them. Dr. Congdon is assistant professor of medicine at Einstein and medical co-director of the COVID-19 Recovery (CORE) Clinic at Montefiore.
Dr. Congdon's Profile
New York Social Diary - May 25, 2022
The Women's Division of Albert Einstein College of Medicine recently held its 67th Spirit of Achievement Luncheon, an annual fundraiser to support biomedical research. The event has raised more than $100 million since its inception.
Additional coverage includes WWD, Park Magazine NY, and Silver Disobedience
Slate - May 25, 2022
Deepika Slawek, M.D., M.S., explains that a harm reduction approach to COVID-19 means using a range of mitigation measures—such as vaccines, boosters, frequent testing, medical-grade masks, and improved ventilation—to lower the risk of contracting the virus. Dr. Slawek is assistant professor of medicine at Einstein and an internist and infectious disease physician at Montefiore.
Dr. Slawek's ProfileMore coverage on Dr. Slawek
BronxNet - May 18, 2022
Jeannette Mahoney, Ph.D., discusses her new NIH grant to examine sensory systems in the brain and detect behavioral markers for Alzheimer's disease. Dr. Mahoney is assistant professor in the Saul R. Korey Department of Neurology at Einstein.
Dr. Mahoney's Profile
NPR - May 10, 2022
Priya Nori, M.D., says people who are diagnosed with COVID-19 benefit from taking the antiviral medication Paxlovid, even if they have been vaccinated or previously infected. Dr. Nori is associate professor of medicine and of orthopaedic surgery at Einstein and medical director of the antimicrobial stewardship program at Montefiore.
Dr. Nori's ProfileMore coverage on Dr. Nori
The New York Times - May 10, 2022
Shelby Freedman Harris, Psy.D., says infants and preschoolers commonly move around during sleep and may end up in positions adults think are awkward, but are comfortable for children. Dr. Harris is clinical associate professor in The Saul R. Korey Department of Neurology and of psychiatry and behavioral sciences at Einstein. (subscription required)
Dr. Harris's ProfileMore coverage on Dr. Harris